Eupry, a Copenhagen, Denmark-based tech company working to protect the supply chain of medicines and environmentally sensitive products, announced that it raised €2.4 million in funding.

The round was led by The Danish Growth Fund Vækstfonden and Ugly Duckling Ventures to help accelerate its international expansion.

The investment will be used for international growth and to strengthen their offerings.

The Danish Growth Fund Vækstfonden will take a seat on the board as a new investor.

Company: Eupry ApS

Raised: €2.4M

Round: Unknown 

Funding Month: Aug 2022

Lead Investors: The Danish Growth Fund Vækstfonden and Ugly Duckling Ventures

Additional Investors: 

Company Website: https://eupry.com/

Software Category: Storage Compliance as a Service

About the Company: Founded in 2012 by Adam Hartmann-Kruckow, Christian Elster Jacobsen, Sigurd Jervelund Hansen, Noam Ritov, and Jakob Konradsen, Eupry provides a complete portfolio of solutions to monitor and perform validation of temperature, Co2, humidity and differential pressure for regulated industries. Eupry is on a mission to secure access to high-quality medication and sensitive products for everyone. With the use of innovative technology, we are demystifying the regulation and simplifying processes for compliant storage and distribution. Eupry supports further development of a host of industries including Laboratory, Pharmacy, Healthcare, Pharma, Food, and more by providing efficient solutions to monitor temperature-sensitive assets.

Source: https://eupry.com/knowledge/eupry-receives-e-2-4m-investment-from-the-danish-growth-fund-and-ugly-duckling-ventures/